HOME >> BIOLOGY >> NEWS
Five UCSF faculty scientists elected to National Academy of Sciences

nals, which play a prominent role in autoimmune diseases. T cells are not activated by stimulation of the receptors stimulation alone, and he also studies signals involving interactions between molecules on an antigen presenting cell and T cells. CD28, a T cell transmembrane protein that binds to molecules expressed on B cells and macrophages, initiates an unidentified signaling event which may activate genes that regulate lymphokine activity. His laboratory seeks to identify the events involved in CD28 signaling and their relative importance in T cell differentiation/activation.

The five UCSF scientists are among 72 new members and 18 foreign associates from 11 countries elected at the 14th annual meeting of the Academy. The National Academy of Sciences is a private organization of scientists, established in 1863 by a congressional act of incorporation, signed by Abraham Lincoln. It serves as an official adviser to the federal government, upon request, in any matter of science or technology.


'"/>

Contact: Wallace Ravven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
1-May-2003


Page: 1 2 3

Related biology news :

1. Biochemist becomes 15th UT Southwestern faculty member serving on National Academy of Sciences
2. UC San Diego faculty receive funding from von Liebig Center to commercialize academic research
3. Research grants available for faculty at minority serving institutions
4. UGA faculty of engineering researchers awarded $1 million NSF grant to develop nanoscale biosensors
5. Funding opportunities for junior faculty offered by the American Association for Cancer Research
6. Von Liebig Center awards funding to six projects to commercialize UCSD faculty research
7. National Jewish faculty to present research at American Thoracic Society
8. Two Hopkins faculty members receive genius awards
9. DNA lends scientists a hand, revealing new chemical reactions
10. Conference at UH opens doors for new scientists, engineers
11. Wisconsin scientists develop quick botox test

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Five UCSF faculty scientists elected National Academy Sciences

(Date:7/23/2014)... Chrysomya megacephala is commonly found in dead bodies ... time of death, referred to as the post mortem ... C. megacephala from Tamil Nadu is provided for ... characterization through generation of DNA barcoding. This study, significant ... Biodiversity Data Journal . , Chrysomya megacephala ...
(Date:7/23/2014)... New Rochelle, NY -- The potential for clinical ... for transplant-based therapeutic strategies has previously been hindered ... the development of tumors. The ability to use ... for the treatment of heart disease, specifically acute ... Stem Cells and Development , a peer-reviewed ...
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
Breaking Biology News(10 mins):Dead body feeding larvae useful in forensic investigations 2MedNet Appoints Clareece West As Chief Operating Officer 2
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... regulated information -- UCB today announced an important advance ... topline results from the latest Phase 3 study ... evaluate the efficacy and safety of brivaracetam ... to placebo, as adjunctive treatment in adult focal ... despite treatment with one or two concomitant antiepileptic ...
(Date:7/23/2014)... 2014  Sofinnova Ventures, a Menlo Park ... of Sofinnova Venture Partners IX, L.P. at the hard ... initial fund target of $425 million. Sofinnova ... Consistent with recent funds, SVP IX will provide capital ... along with select investments in earlier stage opportunities. Investments ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: